-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
(S)-Enzaplatovir
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1323077-88-8.gif)
| Category | Respiratory syncytial Virus (RSV) |
| CAS | 1323077-88-8 |
| Description | (S)-Enzaplatovir is the S-enantiomer of Enzaplatovir. It shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV). |
Product Information
| Synonyms | (S)-BTA-C585 |
| IUPAC Name | (3S)-4-(3-methyl-1,2-oxazole-4-carbonyl)-3-(6-methylpyridin-3-yl)-1,4,7-triazatricyclo[7.3.0.03,7]dodeca-9,11-dien-8-one |
| Molecular Weight | 377.40 |
| Molecular Formula | C20H19N5O3 |
| Canonical SMILES | CC1=NC=C(C=C1)C23CN4C=CC=C4C(=O)N2CCN3C(=O)C5=CON=C5C |
| InChI | InChI=1S/C20H19N5O3/c1-13-5-6-15(10-21-13)20-12-23-7-3-4-17(23)19(27)25(20)9-8-24(20)18(26)16-11-28-22-14(16)2/h3-7,10-11H,8-9,12H2,1-2H3/t20-/m1/s1 |
| InChIKey | KUDXTBCRESIJFH-HXUWFJFHSA-N |
| Purity | 99% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Off-white to yellow (Solid) |
| Storage | Store at -20°C |
| Complexity | 660 |
| Exact Mass | 377.14878949 |
| Target | RSV |
| XLogP3-AA | 0.7 |
